0001127602-23-026945.txt : 20231107
0001127602-23-026945.hdr.sgml : 20231107
20231107160617
ACCESSION NUMBER: 0001127602-23-026945
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231103
FILED AS OF DATE: 20231107
DATE AS OF CHANGE: 20231107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones John Jude
CENTRAL INDEX KEY: 0001959460
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-05998
FILM NUMBER: 231383681
MAIL ADDRESS:
STREET 1: 1166 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MARSH & MCLENNAN COMPANIES, INC.
CENTRAL INDEX KEY: 0000062709
STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411]
IRS NUMBER: 362668272
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1166 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 2123455000
MAIL ADDRESS:
STREET 1: 1166 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: MARSH & MCLENNAN COMPANIES INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: MARLENNAN CORP
DATE OF NAME CHANGE: 19760505
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-11-03
0000062709
MARSH & MCLENNAN COMPANIES, INC.
MMC
0001959460
Jones John Jude
1166 AVENUE OF THE AMERICAS
NEW YORK
NY
10036
1
Chief Marketing Officer
0
Common Stock
2023-11-03
4
M
0
4908
90.785
A
12886
D
Common Stock
2023-11-03
4
S
0
4908
193.0831
D
7978
D
Common Stock
1621.973
I
MMC 401(k) Savings & Investment Plan
Stock Options (Right to Buy)
90.785
2023-11-03
4
M
0
4908
0
D
2029-02-18
Common Stock
4908
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.001 to 193.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
These options were granted on February 19, 2019 and vested in four equal annual installments on February 19th of 2020, 2021, 2022 and 2023.
/s/ Tessa Patti, Attorney-in-fact
2023-11-07